Description:FIELD OF THE INVENTION
[0001] The present disclosure relates generally to compositions for management of dandruff. More specifically, the disclosure is directed to a composition for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, and a carrier oil; wherein the carrier oil is a combination of sesame oil and coconut oil.

BACKGROUND OF THE INVENTION
[0002] Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] Dandruff is a dermatological disorder that has affected people globally irrespective of all age groups, gender or region. It involves the flaking off of small white pieces of dry skin from the scalp and other regions with oil glands. It may be associated with other scalp conditions such as itching, hair-fall etc. Although the disorder is not communicable it may be a cause for concern for hair quality and may also cause embarrassment to some.
[0004] Several remedies for dandruff are available in the market. Varied available commercial preparation (oils, shampoo, cream, gels, or masks) can be employed, but these have to be applied in combinations to achieve the multiple targets. No product is available commercially that can completely target all causes of dandruff or its associated issues such as itching, hair-fall and loss of hair texture. This warrants employment of various commercially available products which either employ synthetic drugs or harmful chemicals. Synthetic components, stabilizers and preservatives affect the shine, texture and strength of normal hair besides their inability to completely eradicate dandruff. This leads to hair-fall and reduces patient compliance. Natural products based compositions are also available but most of these suffer with the issues of efficacy and formulation stability.
[0005] Therefore there is a need in the art to provide compositions that are based on natural components but are stable and efficient in managing dandruff.

OBJECTS OF THE INVENTION
[0006] An object of the present disclosure is to provide a composition for management of dandruff based on natural components.
[0007] Another object of the present disclosure is to provide a composition for management of dandruff that is an anti-bacterial, anti-oxidant, anti-fungal and provides scalp moisturization.
[0008] Yet another object of the present disclosure is to provide a composition that is stable and preservative free.

SUMMARY OF THE INVENTION
[0009] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in Detailed Description section. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
[0010] Aspects of the present disclosure provide a composition that is capable of managing dandruff and associated conditions. The associated conditions may be hair fall, dry skin, brittle hair or poor hair texture.
[0011] In an aspect, the present disclosure provides a composition for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, and a carrier oil; wherein the carrier oil is a combination of sesame oil and coconut oil.
[0012] In an embodiment, the camphor oil may be present in a weight percentage range of about 0.8% to about 4.8% of the composition.
[0013] In an embodiment, the lavender oil may be present in a weight percentage range of about 0.35% to about 2.1% of the composition.
[0014] In an embodiment, the tea tree oil may be present in a weight percentage range of about 0.35% to about 2.1% of the composition.
[0015] In an embodiment, the lemon oil may be present in a weight percentage range of about 0.15% to about 0.9% of the composition.
[0016] In an embodiment, the thyme oil may be present in a weight percentage range of about 0.15% to about 0.9% of the composition.
[0017] In an embodiment, the carrier oil may be present in a weight percentage range of about 88% to about 98% of the composition. In a preferred embodiment, the carrier oil is a combination of coconut oil and sesame oil in a ratio of 3:7 and wherein the coconut oil and sesame oil are cold pressed.
[0018] In an aspect, the present disclosure provides a process of preparing a composition for management of dandruff comprising the steps of mixing camphor oil, lavender oil, tea tree oil, lemon oil, and thyme oil to give a blend and adding this blend to a carrier oil followed by leaving overnight to give the composition; wherein the carrier oil is a combination of sesame oil and coconut oil.
[0019] Other aspects of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learnt by the practice of the invention.

DETAILED DESCRIPTION OF THE INVENTION
[0020] The following is a detailed description of embodiments of the disclosure. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
[0021] All publications herein are incorporated by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
[0022] Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
[0023] In some embodiments, numbers have been used for quantifying weights, percentages, ratios, and so forth, to describe and claim certain embodiments of the invention and are to be understood as being modified in some instances by the term “about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the invention may contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
[0024] Various terms as used herein are shown below. To the extent a term used in a claim is not defined below, it should be given the broadest definition persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing.
[0025] As used in the description herein and throughout the claims that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.
[0026] Unless the context requires otherwise, throughout the specification which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense that is as “including, but not limited to.”
[0027] The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein.
[0028] All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
[0029] Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified.
[0030] The description that follows, and the embodiments described therein, is provided by way of illustration of an example, or examples, of particular embodiments of the principles and aspects of the present disclosure. These examples are provided for the purposes of explanation, and not of limitation, of those principles and of the disclosure.
[0031] It should also be appreciated that the present disclosure can be implemented in numerous ways, including as a system, a method or a device. In this specification, these implementations, or any other form that the invention may take, may be referred to as processes. In general, the order of the steps of the disclosed processes may be altered within the scope of the invention.
[0032] The headings and abstract of the invention provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
[0033] The following discussion provides many example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus, if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0034] As described herein, the term ‘effective amount’ refers to the amount of the composition required to bring about a change or improvement in a subject without side effects or overdosing.
[0035] The term, "subject" as used herein refers to an animal, preferably a mammal, and most preferably a human. The term "mammal" used herein refers to warm-blooded vertebrate animals of the class 'mammalia' , including humans, characterized by a covering of hair on the skin and, in the female, milk-producing mammary glands for nourishing the young, the term mammal includes animals such as cat, dog, rabbit, bear, fox, wolf, monkey, deer, mouse, pig and human.
[0036] The term, ‘management’, or ‘treatment’ as used herein refers to alleviate, slow the progression, attenuation, prophylaxis or as such treat the existing disease or condition. Treatment also includes treating, preventing development of, or alleviating to some extent, one or more of the symptoms of the diseases or condition.
[0037] In an embodiment, the present disclosure provides a composition for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, and a carrier oil; wherein the carrier oil is a combination of sesame oil and coconut oil.
[0038] In an embodiment, the camphor oil may be present in a weight percentage range of about 0.8% to about 4.8%, preferably in a weight percentage range of about 1.2% to about 3.0% of the composition.
[0039] In an embodiment, the lavender oil may be present in a weight percentage range of about 0.35% to about 2.1%, preferably in a weight percentage range of about 0.5% to about 1.0% of the composition.
[0040] In an embodiment, the tea tree oil may be present in a weight percentage range of about 0.35% to about 2.1%, preferably in a weight percentage range of about 0.5% to about 1.0% of the composition.
[0041] In an embodiment, the lemon oil may be present in a weight percentage range of about 0.15% to about 0.9%, preferably in a weight percentage range of about 0.25% to about 0.5% of the composition.
[0042] In an embodiment, the thyme oil may be present in a weight percentage range of about 0.15% to about 0.9%, preferably in a weight percentage range of about 0.25% to about 0.5% of the composition.
[0043] In an embodiment, the carrier oil may be present in a weight percentage range of about 88% to about 98%, preferably in a weight percentage range of about 95% to about 97% of the composition.
[0044] In an embodiment, the coconut oil and sesame oil may be present in a ratio of 5:5 to 1:9. In a preferred embodiment, the carrier oil is a combination of coconut oil and sesame oil in a ratio of 3:7 and wherein the coconut oil and sesame oil are cold pressed.
[0045] In an embodiment, the composition for management of dandruff comprises camphor oil in a weight percentage range of about 1.2% to about 3% of the composition, lavender oil in a weight percentage range of about 0.5% to about 1.0% of the composition, tea tree oil in a weight percentage range of about 0.5% to about 1.0% of the composition, lemon oil in a weight percentage range of about 0.25% to about 0.5% of the composition, thyme oil in a weight percentage range of about 0.25% to about 0.5% of the composition, and a carrier oil in a weight percentage range of about 95% to about 97% of the composition; wherein the carrier oil is a combination of sesame oil and coconut oil.
[0046] In an embodiment, the composition is a liquid formulation. In an embodiment, the composition may be formulated into an oil formulation. The oil formulation may be applied on the scalp, hair or affected skin of a subject for management of dandruff.
[0047] In an embodiment, the present disclosure provides a formulation for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, a carrier oil; and an additive; wherein the carrier oil is a combination of sesame oil and coconut oil.
[0048] In an embodiment, the additive may be selected from fragrance, color, emollient, thickener, moisturizer, water, or combinations thereof. The additives may be selected by a person of skill in the art from those well known in the art, without going beyond the scope of the present disclosure.
[0049] In a preferred embodiment, the composition is effective against Staphylococcus aureus, Escherichia coli, and Candida albicans.
[0050] The composition is effective in managing dandruff and besides reducing dandruff moistens the scalp, improves hair texture and hair strength. In some embodiments, said composition is purely organic, harsh chemicals free and preservative free.
[0051] In some embodiments, the composition has anti-oxidant, anti-bacterial, and anti-fungal effects. The composition is a non-irritant and therefore has high patient compliance. In some embodiments, the composition has a pH of about 5 to 6 for skin compatibility.
[0052] The composition exhibits stability over long periods without issues of rancidity, component separation or toxicities. All components of the composition are from natural sources which are readily available and easy to source.
[0053] The composition is economical, multi-functional and has no adverse short-term or long-term side effects. The composition also shows good flow characteristics that make it easy for application. In some embodiments, the composition has viscosity of about 33cps to about 36cps for good flowability.
[0054] In an embodiment, the present disclosure provides a process of preparing a composition for management of dandruff comprising the steps of mixing camphor oil, lavender oil, tea tree oil, lemon oil, and thyme oil to give a blend and adding this blend to a carrier oil followed by leaving overnight to give the composition; wherein the carrier oil is a combination of sesame oil and coconut oil. The process does not require complex instrumentation to prepare the composition. The production also does not cause any pollution, requires minimum energy, water and labor requirement.
[0055] In an embodiment, the present disclosure provides a method of treating, ameliorating or preventing dandruff and associated conditions in a subject by administering to the subject a therapeutically effective amount of the composition. The associated conditions may be hair-fall, dry skin, brittle hair or poor hair texture. The composition is merely applied on the scalp, hair or affected skin directly or using a cotton ball.
[0056] The compositions may be dispelled from a pump bottle, or a squeeze bottle.
[0057] While the foregoing describes various embodiments of the disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof. The scope of the invention is determined by the claims that follow. The invention is not limited to the described embodiments, versions or examples, which are included to enable a person having ordinary skill in the art to make and use the invention when combined with information and knowledge available to the person having ordinary skill in the art.
EXAMPLES
[0058] The present invention is further explained in the form of following examples. However, it is to be understood that the following examples are merely illustrative and are not to be taken as limitations upon the scope of the invention.
[0059] MATERIALS: The oils were obtained from Haleness Wellspring, Lucknow, Uttar Pradesh. Staphylococcus aureus, (MTCC-1430), Escherichia coli (MTCC-1687)] and fungal Candida albicans (MTCC-227) were obtained as gift sample from Agri-Biotechnology Division, National Agri-Food Biotechnology Institute (NABI), Mohali 140306, India.
[0060] EXAMPLE 1: Anti-dandruff Hair oil
[0061] Four hair oil formulations were prepared as per the list disclosed in Table 1 below. The aromatic/essential oils were added in their respective proportions in decreasing order of their amounts and agitated properly to form a homogenous blend without heating. The aromatic oils were then added to the 7:3 combination of carrier oil of cold pressed sesame oil and coconut oil. The formulation was left undisturbed overnight.
Table 1: Different hair oil formulations
Formulation Code Camphor Oil (%v/v) Lavender Oil (%v/v) Tea tree Oil (%v/v) Lemon Oil (%v/v) Thyme Oil (%v/v) Base (Sesame: Coconut oil; 70:30) qs
A 4.8 2.1 2.1 0.9 0.9 100ml
B 3.2 1.4 1.4 0.6 0.6 100ml
C 1.6 0.7 0.7 0.3 0.3 100ml
D 0.8 0.35 0.35 0.15 0.15 100ml

[0062] EXAMPLE 2: Organoleptic and microbial evaluations
[0063] The prepared hair oil formulations of Table 1 were subjected to organoleptic and microbial evaluations.
2.1 Preparation of microbial culture
[0064] A loop full of lyophilized bacterial [S. aureus, (MTCC-1430), E. coli (MTCC-1687)] and fungal [C. albicans (MTCC-227)] strains were inoculated, separately, in nutrient broth and sabouraud dextrose broth, respectively and incubated at 37 °C for 48-72h. The strains were later sub-cultured in respective sterilized media and 24h old culture was employed for further analysis.
2.2 Cell count by turbidometric method
[0065] Active bacterial and fungal cultures (24h old) were analyzed spectrophotometrically at 600nm and 530nm respectively, taking their respective media (nutrient broth and sabouraud dextrose broth) as blank. The absorbance value of the culture was adjusted to achieve final culture concentration equivalent to 0.5 McFarland standards. The sample was diluted with broth till absorbance values reached the detectable limits and the total cell count in sample was calculated by multiplying colonies count with the dilution employed.
2.3 Determination of Minimum Inhibitory Concentration (MIC):
[0066] MIC was determined by incorporating different concentrations of the formulations of Table 1 in 5 ml nutrient and sabouraud’s dextrose broth. The medium with oil was then emulsified thoroughly with Tween 20 (5% v/v). 100 µL of prepared cell suspensions (S. aureus, E. coli and C. albicans strain; OD600&530 = 1.0) was added separately to the test tubes containing 5 mL of prepared different formulations. The test tubes were incubated at 37 °C for 5-7 h. Thereafter, 50 µL of this suspension was spread over the petriplates containing sterilized respective agar media and incubated at 37 °C for 24-48h. The petriplates were then analyzed for cell count and the formulation with minimum concentration which exhibited no growth was taken as MIC value and considered as optimized formulation and used for further analysis.
[0067] Results of the microbial studies revealed the formulations exhibit efficacy against test organisms. The oil formulations exhibited antibacterial and antifungal efficacy as represented in Table 2 below.
Table 2: Effect of different oil formulations against E. coli, S. aureus and C. albicans
Formulation Code Microbial strains
E. coli S. aureus C. albicans
A - - -
B - - -
C - - -
D - + +

[0068] The results showed that minimum amount of extracts required to exhibit antimicrobial effects were present in the formulation code C. Therefore, formulation with code C was chosen as optimized formulation for all other tests. This formulation was found to be clear, yellow in color, with characteristic odor of carrier oil and aromatic oils. The formulation was found to possess pH of 5.6 with viscosity of 35cp. The values indicate its tissue compatibility and easy flowable nature.
2.4 Zone of inhibition studies:
[0069] Diffusion dependent antimicrobial activity of the formulations was studied by the zone of inhibition method. 50 µL of active fungal and bacterial inoculum (equivalent to 0.5 McFarland standards) were uniformly inoculated separately on the surface of the Sabouraud’s and Nutrient agar medium, respectively. Wells were made in the center of the mediums using sterile borer and the 100 µL Tween emulsified formulations were loaded into the well. After allowing diffusion of solution into the medium, plate was incubated at 37 °C for 24-48h. The zone of inhibition was measured and anti-microbial property of the formulations was compared with that of standard and control.
[0070] Agar diffusion assay revealed the Formulation C (oil formulation) exhibits antimicrobial effects, against varied bacterial and fungal strains, similar to that of commercial preparation as can be observed from the Figure 1 and Table 3; both depicting almost similar zones of inhibition.
Table 3: Zones of inhibition (diameter) against test organisms
Formulation E. coli S. aureus C. albicans
Formulation C 1.73±0.06 cm 1.60±0.04 cm 2.35±0.04 cm
Ketoconazole Standard (Kevon®) NA NA 2.52±0.02 cm
Base Oil 0.93±0.05 cm 0.97±0.05 cm 1.0±0.041 cm

2.5 Antioxidant activity:
[0071] The DPPH radical scavenging test was used to determine the antioxidant activity. One mL of oil formulation C was added to one ml of DPPH solution (0.2mM in acetone). After 30 minutes of reaction at room temperature, the absorbance of the solution was measured at 517nm. The formulation demonstrated appreciable antioxidant effects (refer Table 4). It showed around 82% inhibition of DPPH.
2.6 Primary skin irritation test:
[0072] The prepared formulation C was assessed for primary skin irritation test by applying on the test site on the forearm a small amount of the formulation. The test site was observed for erythema or edema for 3 to 4 hrs. The topical application of prepared formulation on the skin of human volunteers yielded no signs of erythema or edema when observed for 3 to 4 hrs. This indicated its biocompatible nature and its safety for human use.
2.7 Test for microbial growth:
[0073] 50 µL of the optimized tween emulsified formulation C was spread over the plates containing sterilized solidified agar media with the help of sterilized spreader. Simultaneously, positive and negative control media were prepared containing microbial strains and blank media, respectively. The plates were incubated at 37°C for 24-48h. After the incubation period plates were taken out and checked for microbial growth and were compared with that of control. The test was conducted to check the sterility/contamination status of the formulation. No growth was observed upon incubation of the formulation to nutrient media, indicating its sterile nature.
2.8 Stability studies:
[0074] Prepared formulation C was observed for short term stability condition by storing the same in glass container at room temperatures for 3 months. The formulation was kept aside and observed after 1, 2 and 3 months intervals for various organoleptic features. The stability studies conducted on the formulation for a period of 3 months indicated the retention of physiological characteristics of oil and values of various parameters including its antimicrobial activities are provided in Table 4. The values were found to be similar to that of freshly prepared formulations, thereby indicating the non-significant alterations upon storage and stable nature of the formulations.

Table 4: Stability studies of formulation C
Parameter Time interval
0 Month 1 Month 2 Months 3 Months
Color Yellow Yellow Yellow Yellow
Smoothness Smooth & non-sticky Smooth & non-sticky Smooth & non-sticky Smooth & non-sticky
Odor Characteristic Characteristic Characteristic Characteristic
Specific gravity (g/cm3) 0.914±0.0017 0.913±0.0016 0.914±0.0024 0.92±0.0021
pH 5.55±0.093 5.47±0.142 5.57±0.115 5.50±0.136
Viscosity (cp) 33.1±1.93 35.0±1.76 35.6±2.79 35.17±2.65
Refractive Index 1.45±0.008 1.45±0.006 1.45±0.009 1.45±0.008
Skin Irritation No Irritation No Irritation No Irritation No Irritation
Antioxidant activity (%) 82.3±2.54 83.5±2.46 82.43±2.58 81.7±1.37
ZOI (E.coli); cm 1.73±0.06 1.67±0.05 1.58±0.05 1.63±0.06
ZOI (S.aureus); cm 1.60±0.04 1.53±0.06 1.65±0.04 1.55±0.04
ZOI (C.albicans); cm 2.35±0.04 2.31±0.02 2.40±0.04 2.37±0.02

[0075] Thus, the composition of the present disclosure is capable of use as an anti-dandruff composition and has a long shelf-life.
[0076] EXAMPLE 3: Zone of inhibition studies
[0077] Diffusion dependent antimicrobial activity of the each of the component oils of the formulation was studied by the zone of inhibition method. 50 µL of active fungal and bacterial inoculum (equivalent to 0.5 McFarland standards) were uniformly inoculated separately on the surface of the Sabouraud’s and Nutrient agar medium, respectively. Wells were made in the center of the mediums using sterile borer and the components were loaded into the well. After allowing diffusion of solution into the medium, plate was incubated at 37 °C for 24-48h. The zone of inhibition was measured and anti-microbial property of the components was compared with the oil formulation.
Table 5: Zones of inhibition (diameter) against test organisms
Essential oils (%v/v) Amount (%v/v) Anti-bacterial (ZOI; cm) Anti-fungal (ZOI; cm)
(C. albicans)

(E. coli) (S. aureus)
Camphor Oil 1.6 0.8±0.05 - 1.30±0.05
Lavender Oil 0.7 0.97±0.05 1.1±0.12 -
Tea tree Oil 0.7 1.1±0.05 1.4±0.05 1.6±0.05
Lemon Oil 0.3 1.2±0.05 0.9±0.05 1.2±0.05
Thyme Oil 0.3 1.3±0.05 1.3±0.05 1.4±0.04
Base oil (Sesame : Coconut) 7:3 0.93±0.05 0.97±0.05 1.0±0.041
Oil Formulation - 1.73±0.06 1.60±0.04 2.35±0.04

[0078] The foregoing examples are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the invention.

ADVANTAGES OF THE PRESENT INVENTION
[0079] The composition of the present disclosure is stable, non-toxic, economical and environmentally friendly.
[0080] The composition of the present disclosure is effective as an anti-fungal, anti-oxidant, and anti-bacterial composition.

We Claims:

1. A composition for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, and a carrier oil; wherein the carrier oil is a combination of sesame oil and coconut oil.
2. The composition as claimed in claim 1, wherein the camphor oil is present in a weight percentage range of 0.8% to 4.8% of the composition.
3. The composition as claimed in claim 1, wherein the lavender oil is present in a weight percentage range of 0.35% to 2.1% of the composition.
4. The composition as claimed in claim 1, wherein the tea tree oil is present in a weight percentage range of 0.35% to 2.1% of the composition.
5. The composition as claimed in claim 1, wherein the lemon oil is present in a weight percentage range of 0.15% to 0.9% of the composition.
6. The composition as claimed in claim 1, wherein the thyme oil is present in a weight percentage range of 0.15% to 0.9% of the composition.
7. The composition as claimed in claim 1, wherein the carrier oil is present in a weight percentage range of 88% to 98% of the composition.
8. The composition as claimed in claim 1, wherein the carrier oil is a combination of coconut oil and sesame oil in a ratio of 3:7 and wherein the coconut oil and sesame oil are cold pressed.
9. The composition as claimed in claim 1, wherein the composition comprises camphor oil in a weight percentage range of 1.2% to 3% of the composition, lavender oil in a weight percentage range of 0.5% to 1.0% of the composition, tea tree oil in a weight percentage range of 0.5% to 1.0% of the composition, lemon oil in a weight percentage range of 0.25% to 0.5% of the composition, thyme oil in a weight percentage range of 0.25% to 0.5% of the composition, and a carrier oil in a weight percentage range of 95% to 97% of the composition.
10. A formulation for management of dandruff comprising camphor oil, lavender oil, tea tree oil, lemon oil, thyme oil, a carrier oil; and an additive; wherein the carrier oil is a combination of sesame oil and coconut oil.
11. A process of preparing a composition for management of dandruff comprising the steps of mixing camphor oil, lavender oil, tea tree oil, lemon oil, and thyme oil to give a blend and adding this blend to a carrier oil followed by leaving overnight to give the composition; wherein the carrier oil is a combination of sesame oil and coconut oil.